Release and degradation of neurotensin during perfusion of rat small intestine with lipid
- PMID: 3840906
- DOI: 10.1016/0167-0115(85)90191-0
Release and degradation of neurotensin during perfusion of rat small intestine with lipid
Abstract
The levels of neurotensin (NT) and its metabolite, the N-terminal octapeptide (NT1-8), identified by HPLC and measured by RIA, were increased in the hepatic-portal circulation of the anesthetized rat during perfusion of the small intestine with a lipid solution, while levels of both peptides remained unchanged in the general circulation. There was no significant arteriovenous difference for NT or NT1-8 during saline perfusion of the small intestine. Plasma collected from the superior mesenteric vein during the infusion of [3H]NT into the superior mesenteric artery showed major peaks of radioactivity with the retention times of NT1-8 and NT1-11 on HPLC. Only 12% of the radioactivity recovered from plasma was intact NT. These studies demonstrate that chromatographically identified NT and its metabolite, NT1-8, are elevated in the portal circulation but not systemic circulation during lipid perfusion and that the small intestine may be both the site of release and metabolism of NT.
Similar articles
-
Alcohol and fatty acid stimulation of neurotensin release from rat small intestine.Endocrinology. 1985 Mar;116(3):1133-8. doi: 10.1210/endo-116-3-1133. Endocrinology. 1985. PMID: 3971900
-
Neurotensin stimulates [3H]oleic acid translocation across rat small intestine.Am J Physiol. 1986 Dec;251(6 Pt 1):G823-9. doi: 10.1152/ajpgi.1986.251.6.G823. Am J Physiol. 1986. PMID: 3789148
-
Luminal bile salts and neurotensin release in the isolated vascularly perfused rat jejuno-ileum.Endocrinology. 1994 Feb;134(2):603-7. doi: 10.1210/endo.134.2.8299558. Endocrinology. 1994. PMID: 8299558
-
Elevation of plasma neurotensin during lipid perfusion of rat small intestine.Peptides. 1981;2 Suppl 2:263-6. doi: 10.1016/0196-9781(81)90042-5. Peptides. 1981. PMID: 7343961
-
Inhibition of neurotensin release by a cyclic hexapeptide analog of somatostatin.Peptides. 1985 Sep-Oct;6(5):945-8. doi: 10.1016/0196-9781(85)90326-2. Peptides. 1985. PMID: 2867526
Cited by
-
Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells.Clin Cancer Res. 2006 Sep 15;12(18):5346-55. doi: 10.1158/1078-0432.CCR-06-0968. Clin Cancer Res. 2006. PMID: 17000667 Free PMC article.
-
Neurotensin pathway in digestive cancers and clinical applications: an overview.Cell Death Dis. 2020 Dec 2;11(12):1027. doi: 10.1038/s41419-020-03245-8. Cell Death Dis. 2020. PMID: 33268796 Free PMC article. Review.
-
Fasting Neurotensin Levels in Pediatric Celiac Disease Compared with a Control Cohort.Gastroenterol Res Pract. 2020 Feb 22;2020:1670479. doi: 10.1155/2020/1670479. eCollection 2020. Gastroenterol Res Pract. 2020. PMID: 32148474 Free PMC article.
-
[Metabolic parameters and neurotensin liberation after resection of the small intestine, syngeneic and allogeneic segment transplantation the rat].Langenbecks Arch Chir. 1993;378(5):265-72. doi: 10.1007/BF00183963. Langenbecks Arch Chir. 1993. PMID: 8412434 German.
-
Characterization of promoter elements regulating the expression of the human neurotensin/neuromedin N gene.J Biol Chem. 2011 Jan 7;286(1):542-54. doi: 10.1074/jbc.M110.145664. Epub 2010 Oct 28. J Biol Chem. 2011. PMID: 21030593 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials